"We have to choose the right path in Life Science"

JENNI NORDBORG: I am hardly exaggerating when I claim that right now, the future of Stockholm, Sweden, and Europe in Life Science is at stake. We have to get EU governments and Brussels bureaucrats to choose the right path – the one that leads to increased companies' research investments, new medicines being researched and developed within the EU, and Life Science clusters like the one we have in Stockholm continuing to develop.

Results from FOKUS Patients' survey

FOKUS Patient® is a meeting place for discussing healthcare issues and life science. In March, for the third time, they surveyed the patient and disability movement in Sweden. The questions concerned information, organization, finance, communication and education-knowledge. 

Subscribe to